A new article published this month is presented by the University of Texas MD Anderson Cancer Center Department of Sarcoma Medical Oncology. Understanding Sarcoma Drug Resistance One Cell at a Time discusses that the focus in GIST research is moving from the current focus on just histology, proteomics, and tumor genetics enabled by tumor samples, cell lines and mouse models which are limited in rare cancers like SDH-deficient GIST.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Paul Nadolny shares his story.
Chelsea Madia has been an extraordinary volunteer and fundraiser for the LRG! We appreciate all she has done.
Jimit Mody shares his GIST journey and how a positive attitude and determination keeps him going.
December 2021 - In this summary, we have highlighted recent clinical trials that are still recruiting in the U.S. which investigate potential treatments for GIST patients.
As we enter the holiday season, and our thoughts turn to the new year to come, we made a list of our holiday wishes. - That no patient dies because they didn’t receive the [...]
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Americo Blancato shares his story.
n June 2021, we trained seven LRG members from Austria, Canada, Chile, India, and Singapore. LRG’s Global GIST Mentors are survivors or caregivers who volunteer their time, energy, and talent to support others.
Every GIST patient (and person in general) is unique, however, there are some common issues that patients may face during their GIST journey.
Our GEM Donor Program has a group of new donors that will help the LRG continue the work we do with patients and #GISTresearch. Our thanks go out to our newest GEM!
